Volume 15 Supplement 2
Association of single nucleotide polymorphisms in FOXE1 and pre-MIR146A with papillary thyroid carcinoma
© Bagatian et al; licensee BioMed Central Ltd. 2014
Published: 2 April 2014
Papillary thyroid carcinoma (PTC) is one of the most common cancer types in the Middle East and North African (MENA) region and more abundant than in many other world regions suggesting that genetic susceptibility factors for this malignancy are likely to vary between the populations studied. We assessed in a population from the MENA region the allele frequencies of two SNPs which may bear the capacity to confer risk for developing PTC. SNP rs2910164 is a sequence polymorphism in the precursor microRNA (mir)146a. The heterozygous C/G state of rs2910164 was found to be associated with a reduced amount of mir146a which in turn had an effect on the efficiency to inhibit target genes as CCDC6 [1, 2]. SNP rs1867277 is located 283 bp upstream of the translational start site of the developmental gene encoding forkhead box E1 (FOXE1) and identified as an associated risk factors for a number of solid tumors including PTC [3, 4].
Materials and methods
SNPs rs2910164 and rs1867277 were investigated in patients with PTC and volunteers without a thyroid disease (case and control group each, N=207-234) using PCR, including a multiplex PCR step on genomic DNA, to amplify each SNP region. PCR products were directly sequenced. For Hardy-Weinberg (HW) equilibrium testing the Online Encyclopedia for Genetic Epidemiology studies (http://www.oege.org) was used. Odds ratios (ORs) and 95% confidence intervals (CI) were calculated using the online VassarStats website for statistical computation (http://vassarstats.net/index.html) and considered to be statistically significant for a P-value ˂ 0.05.
Both SNPs rs2910164 (mir146a) and rs1867277 (FOXE1) were in HW disequilibrium in the patient group (X2 = 8.33 and X2 = 8.29, respectively) but in equilibrium in the control group (X2 = 0.87 and X2 = 1.56, respectively). For rs2910164 a trend association with PTC was found for the heterozygous C/G state when compared to the combined C/C+G/G states (OR = 0.51, CI 0.51-1.1, P = 0.11). For rs1867277 the risk allele A was significantly associated with PTC in comparison to allele G (OR = 1.94, CI 1.48-2.53, P < 0.0001).
The HW disequilibrium of SNP rs1867277 in the PTC group and its significant association of risk allele A with PTC let us suggest that this SNP in the developmental FOXE1 gene may represent an additive risk factor for developing PTC in the investigated population.
This study was supported by King Abdulaziz City for Science and Technology (KACST) grants 09-BIO707-03 and 09-BIO820-03.
- Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A: Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 2008, 105: 7269-7274.PubMed CentralView ArticlePubMedGoogle Scholar
- Wei WJ, Wang YL, Li DS, Wang Y, Wang XF, Zhu YX, Yang YJ, Wang ZY, Ma YY, Wu Y, et al: Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis. PloS one. 2013, 8: e56638-PubMed CentralView ArticlePubMedGoogle Scholar
- Bullock M, Duncan EL, O'Neill C, Tacon L, Sywak M, Sidhu S, Delbridge L, Learoyd D, Robinson BG, Ludgate M, et al: Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab. 2012, 97: E1814-1819.View ArticlePubMedGoogle Scholar
- Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, et al: The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS genetics. 2009, 5: e1000637-PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.